| Analysis | Samples | Factors | Units |
|---|---|---|---|
| GCMS (Serum fatty acids) | 101 | Strain:AHR -/- | Treatment:Control | Peak area |
| GCMS (Serum fatty acids) | 102 | Strain:AHR -/- | Treatment:Control | Peak area |
| GCMS (Serum fatty acids) | 103 | Strain:AHR -/- | Treatment:Control | Peak area |
| GCMS (Serum fatty acids) | 104 | Strain:AHR -/- | Treatment:Control | Peak area |
| GCMS (Serum fatty acids) | 105 | Strain:AHR -/- | Treatment:Control | Peak area |
| GCMS (Serum fatty acids) | 201 | Strain:AHR -/- | Treatment:TCDF Treatment | Peak area |
| GCMS (Serum fatty acids) | 202 | Strain:AHR -/- | Treatment:TCDF Treatment | Peak area |
| GCMS (Serum fatty acids) | 203 | Strain:AHR -/- | Treatment:TCDF Treatment | Peak area |
| GCMS (Serum fatty acids) | 204 | Strain:AHR -/- | Treatment:TCDF Treatment | Peak area |
| GCMS (Serum fatty acids) | 205 | Strain:AHR -/- | Treatment:TCDF Treatment | Peak area |
| GCMS (Serum fatty acids) | 301 | Strain:WT | Treatment:Control | Peak area |
| GCMS (Serum fatty acids) | 302 | Strain:WT | Treatment:Control | Peak area |
| GCMS (Serum fatty acids) | 303 | Strain:WT | Treatment:Control | Peak area |
| GCMS (Serum fatty acids) | 304 | Strain:WT | Treatment:Control | Peak area |
| GCMS (Serum fatty acids) | 305 | Strain:WT | Treatment:Control | Peak area |
| GCMS (Serum fatty acids) | 401 | Strain:WT | Treatment:TCDF Treatment | Peak area |
| GCMS (Serum fatty acids) | 402 | Strain:WT | Treatment:TCDF Treatment | Peak area |
| GCMS (Serum fatty acids) | 403 | Strain:WT | Treatment:TCDF Treatment | Peak area |
| GCMS (Serum fatty acids) | 405 | Strain:WT | Treatment:TCDF Treatment | Peak area |
| GCMS (Liver) | 101 | Strain:AHR -/- | Treatment:Control | Peak area |
| GCMS (Liver) | 102 | Strain:AHR -/- | Treatment:Control | Peak area |
| GCMS (Liver) | 103 | Strain:AHR -/- | Treatment:Control | Peak area |
| GCMS (Liver) | 104 | Strain:AHR -/- | Treatment:Control | Peak area |
| GCMS (Liver) | 105 | Strain:AHR -/- | Treatment:Control | Peak area |
| GCMS (Liver) | 201 | Strain:AHR -/- | Treatment:TCDF Treatment | Peak area |
| GCMS (Liver) | 202 | Strain:AHR -/- | Treatment:TCDF Treatment | Peak area |
| GCMS (Liver) | 203 | Strain:AHR -/- | Treatment:TCDF Treatment | Peak area |
| GCMS (Liver) | 204 | Strain:AHR -/- | Treatment:TCDF Treatment | Peak area |
| GCMS (Liver) | 205 | Strain:AHR -/- | Treatment:TCDF Treatment | Peak area |
| GCMS (Liver) | 301 | Strain:WT | Treatment:Control | Peak area |
| GCMS (Liver) | 302 | Strain:WT | Treatment:Control | Peak area |
| GCMS (Liver) | 303 | Strain:WT | Treatment:Control | Peak area |
| GCMS (Liver) | 304 | Strain:WT | Treatment:Control | Peak area |
| GCMS (Liver) | 305 | Strain:WT | Treatment:Control | Peak area |
| GCMS (Liver) | 401 | Strain:WT | Treatment:TCDF Treatment | Peak area |
| GCMS (Liver) | 402 | Strain:WT | Treatment:TCDF Treatment | Peak area |
| GCMS (Liver) | 403 | Strain:WT | Treatment:TCDF Treatment | Peak area |
| GCMS (Liver) | 405 | Strain:WT | Treatment:TCDF Treatment | Peak area |
Return to study ST000233 main page
Download data matrix(Metabolomics Reveals that Aryl Hydrocarbon Receptor Activation by Environmental Chemicals Induces Systemic Metabolic Dysfunction in Mice (Part II) GCMS (Serum fatty acids))
Download data matrix(Metabolomics Reveals that Aryl Hydrocarbon Receptor Activation by Environmental Chemicals Induces Systemic Metabolic Dysfunction in Mice (Part II) GCMS (Liver))
- Metabolomics Workbench
|